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Abstract
Background/Aims
Studies of human cadaveric pancreas specimens indicate that pancreas inflammation plays
an important role in type 1 diabetes pathogenesis. Due to the inaccessibility of pancreas in
living patients, imaging technology to visualize pancreas inflammation is much in need. In
this study, we investigated the feasibility of utilizing ultrasound imaging to assess pancreas
inflammation longitudinally in living rats during the progression leading to type 1 diabetes
onset.
Methods
The virus-inducible BBDR type 1 diabetes rat model was used to systematically investigate
pancreas changes that occur prior to and during development of autoimmunity. The nearly
100% diabetes incidence upon virus induction and the highly consistent time course of this
rat model make longitudinal imaging examination possible. A combination of histology,
immunoblotting, flow cytometry, and ultrasound imaging technology was used to identify
stage-specific pancreas changes.
Results
Our histology data indicated that exocrine pancreas tissue of the diabetes-induced rats
underwent dramatic changes, including blood vessel dilation and increased CD8+ cell
infiltration, at a very early stage of disease initiation. Ultrasound imaging data revealed sig-
nificant acute and persistent pancreas inflammation in the diabetes-induced rats. The pan-
creas micro-vasculature was significantly dilated one day after diabetes induction, and large
blood vessel (superior mesenteric artery in this study) dilation and inflammation occurred
several days later, but still prior to any observable autoimmune cell infiltration of the pancre-
atic islets.
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Conclusions
Our data demonstrate that ultrasound imaging technology can detect pancreas inflamma-
tion in living rats during the development of type 1 diabetes. Due to ultrasound’s established
use as a non-invasive diagnostic tool, it may prove useful in a clinical setting for type 1 diabe-
tes risk prediction prior to autoimmunity and to assess the effectiveness of potential
therapeutics.
Introduction
Type 1 diabetes is caused by the autoimmune destruction of insulin-producing β-cells within
the pancreatic endocrine islets, and both genetics and the environment play etiological roles
[1–3]. A mechanistic understanding of the causes of type 1 diabetes remains elusive due to
inaccessibility of the target organ—pancreas. Biopsies of the pancreata of type 1 diabetic
patients have been performed, but these studies have been halted due to severe adverse side
effects [4, 5]. Thanks to the increasing availability of cadaveric pancreas specimens from orga-
nizations, such as the Network of Pancreatic Organ Donors (nPOD), many unexpected type 1
diabetes pathologic features in the human pancreas have recently been revealed [6–8].
In general, type 1 diabetes is caused by autoimmune destruction of β-cells within the pan-
creatic islets. Therefore, because the islets constituent only a small fraction (~2%) of the entire
pancreas, it was at first surprising that pancreata from type 1 diabetic organ donors showed
significant reductions in pancreas weight and volume compared to those of non-diabetics [9].
Moreover, immunostaining of human pancreatic tissue showed many type 1 diabetic donors
with higher CD8 T cell density in the exocrine tissue [10], which is not typically an autoim-
mune target, although circulating autoantibodies against exocrine proteins and enzymes have
been reported [11]. Conversely, the expected immune cell infiltration in pancreatic islets
(termed insulitis) of type 1 diabetic donors was not uniformly observed [12]. Analyses of global
gene expression profiles of pancreata and islets from the same type 1 diabetic donors revealed
that many more pathways were transcriptionally altered in pancreata than in islets, including
those for chemotaxis, inflammation, innate immunity, and IFN response [13]. Furthermore, a
proteomic analysis of human pancreata found significant upregulation of proteins involved in
inflammation from type 1 diabetic donors, as well as autoantibody-positive non-diabetic
donors [14]. Together, these data suggest that innate immunity and inflammation of the exo-
crine pancreas may play an important pathogenic role in type 1 diabetes.
Currently, there is no method for identifying pre-diabetic patients at the very early stage of
disease initiation, which would be essential for employing potential preventative strategies. If
pancreas inflammation can be assessed in the clinic, this may serve as an early indicator of dis-
ease initiation. In general, the inflammatory response involves changes in blood vessel and
blood flow characteristics. In this study, we chose to use ultrasound imaging technology to
visualize and monitor pancreas inflammation, not only because ultrasound is an excellent tool
to assess blood vessel and blood flow characteristics, but also because it is a non-invasive tool
routinely used in the clinics which will facilitate easier translation of this detection method to
the clinics.
We used the virus-inducible BBDR rat model 1) to systematically investigate stage-specific
changes in whole pancreas that occur prior to and during autoimmune insulitis by histology,
immunoblotting and flow cytometry analyses, and 2) to explore whether ultrasound imaging
technology can reveal autoimmune diabetes-specific changes longitudinally. In previous
Ultrasound imaging to predict type 1 diabetes risk
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studies, we have carefully defined the stages of autoimmune diabetes pathogenesis in this rat
model [15, 16]. The nearly 100% diabetes onset rate upon induction and the highly consistent
time course of this model make longitudinal imaging examination possible. To our knowledge
this is the first study to visualize pancreas inflammation, prior to insulitis, during the progres-
sion to autoimmune type 1 diabetes.
Materials and methods
Animals
BioBreeding Diabetes Resistant (BBDR) rats were bred at UMASS. Animals were housed
in a viral-antibody-free facility in accordance with our Institutional Animal Care and Use
Committee. All animal work in this study was approved by the University of Massachusetts
IACUC committee (protocol 1766). Anesthesia used was ketamine, euthanasia was by cardiac
bleed.
Diabetes induction
BBDR rats of either sex and 21–24 days old were pre-treated by i.p. injection with polyinosi-
nic:polycytidylic acid (pIC, a viral mimetic) (1–2 μg/g body weight) on three consecutive days
(days -3, -2, and -1); pIC (Sigma-Aldrich, St. Louis, MO) was dissolved in Dulbecco’s PBS.
Rats received a single i.p. dose of 1x107 PFUs of Kilham rat virus (KRV) on day 0. Control
rats received i.p. injections of PBS on the same days. Rats were tested for glycosuria (Clinistix,
Bayer, Elkhart, IN) at day 10–11 post-KRV treatment. Diabetes was confirmed by blood glu-
cose>14 mmol/l on two consecutive days (Accu-Chek Aviva, Roche Diagnostics, Indianapo-
lis, IN).
Pancreatic histology and immunofluorescence staining
Rat pancreata were fixed in 10% buffered formalin and paraffin embedded. Sections were
stained with hematoxylin and eosin (H&E) or anti-rat CD8a (BioLegend, San Diego, CA) and
guinea pig anti-insulin (Dako, Carpinteria, CA). Briefly, the fixed sections were blocked with
PBS-AT (2% BSA grade J and 0.5% Triton X-100 in PBS). Sections were incubated with pri-
mary antibody at 4˚C overnight. After three washes with PBS, the sections were incubated
with secondary antibody at room temperature for 1 hour followed by three washes in PBS.
Mounting medium, Vectashield with DAPI, (Vector Laboratories, Inc., Burlingame, CA,
USA) was added to the sections. Alexa Fluor 488 and 594 secondary antibodies were from
Invitrogen (Carlsbad, CA); isotype controls were from BD Bioscience (San Jose, CA). Images
were acquired with a Nikon Eclipse Ti series microscope and analyzed with Nikon Elements
image analysis software.
Isolation of islets and pancreas-infiltrated immune cells
Pancreatic islets from rats were isolated by collagenase digestion as described [17, 18], snap-
frozen in liquid nitrogen, and stored at -80˚C until use. To recover pancreatic immune cells,
all supernatants from the islet isolation procedure were collected and pooled together on ice
until centrifuged at 1000 RPM for 15 sec to remove residual exocrine tissue. The clear superna-
tant was centrifuged at 1500 RPM for 5 min, and the resulting cell pellet containing the pan-
creas immune cells was washed twice with PBS+0.5% BSA and resuspended in 300ul of MACS
staining buffer (PBS-BSA-EDTA).
Ultrasound imaging to predict type 1 diabetes risk
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FACS analysis of pancreas-infiltrated immune cells
Antibodies for FACS staining included anti-rat CD45, clone OX-1; anti-rat CD3, clone G4.18;
anti-rat CD161a, clone 10/78; and anti-rat CD8, clone OX-8 (BioLegend). Intracellular stain-
ing was done following the standard protocol, and samples were analyzed on LSRII or FACS-
Calibur instruments (BD Biosciences). Data analysis was performed with FlowJo (Tree Star,
Inc., Ashland, OR) software.
Immunoblot analysis of isolated islets and whole pancreata
Whole pancreas or isolated islets were recovered from individual rats and lysed with T-PER
tissue protein extraction reagent (Thermo-Scientific, Rockford, IL); protein concentrations
were determined by bicinchoninic acid protein assay (Sigma-Aldrich). Protein samples were
mixed with 4X SDS-PAGE loading buffer, and loaded onto 4–20% precast Tris-glycine gradi-
ent gels (Invitrogen, Grand Island, NY). Densitometric analyses were performed with Adobe
Photoshop, normalized to actin levels and presented as average±STDEV. Antibodies included
rabbit anti-human caspase-3 (Cell Signaling, Beverly, MA); mouse anti-actin (Chemicon Inter-
national, Billerica, MA) was used as a loading control. Secondary IgG-HRP conjugates were
from Santa Cruz Biotechnology (Santa Cruz, CA).
Ultrasound imaging on large blood vessels and organs of live rats
Vevo 2100 micro-ultrasound system from VisualSonics (Toronto, Ontario, Canada) was used
for visualization of anatomical structures down to 30 microns. Rats were individually posi-
tioned on a Vevo Imaging Station; isoflurane-based anesthesia delivery, body temperature,
electrocardiogram, respiration, blood pressure, and heart rate were monitored throughout the
imaging session. Two-Dimensional Ultrasound and Color Doppler were used to identify
major arterial and venous structures that feed the various organs, such as aorta, renal artery,
superior mesenteric artery, celiac artery, splenic artery, and iliac arteries, as well as the organs
including pancreas, spleen and kidney. The 2D imaging was then mathematically rendered
into 3D imaging using the software developed by VisualSonics.
Perfusion study on small vessels/capillaries using ultrasound
MicroMarker Contrast Imaging Mode combined with Non-Linear Contrast Mode was used to
quantify small vessels/capillaries of selected organs, including pancreas, spleen and kidney.
50 μL of 1x108 micro-bubbles was perfused over a 3 second time period by intravenous injec-
tion into the tail vein using a size A 27-gauge butterfly cannula (Terumo Medical Corporation,
Somerset, NJ). The contrast agent (kindly provided by VisualSonics) was lipid-shelled micro-
bubbles, 2–3 microns in size, which extends detectability down to 2–3 microns. Perfusion
kinetics were assessed by measuring wash-in area, wash-in rate, and peak enhancement.
Quantification of blood flow in large blood vessel using ultrasound
Blood flow in the blood vessel of interest was quantified by measuring peak systolic and end
diastolic velocities using Pulsed Wave Doppler Mode. Resistivity index reflects the vessel resis-
tance to blood flow and was calculated as follows: Resistivity index = (Peak Systolic Velocity—
End Diastolic Velocity) / Peak Systolic Velocity.
Statistical analysis
Statistical analysis was performed by Kaplan-Meier or unpaired t-test using Prism 5 (Graph-
Pad Software, La Jolla, CA); p value <0.05 was considered statistically significant.
Ultrasound imaging to predict type 1 diabetes risk
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Results
Pancreas inflammation is observed prior to insulitis in diabetes-induced
rats
We have previously shown that nearly 100% of pIC+KRV treated rats develop diabetes follow-
ing a highly reproducible time course, with detectable insulitis beginning around 11 days
and acute hyperglycemia after 14 to 18 days post-induction [15, 16]. To investigate changes
within the entire pancreas, pancreata from diabetes-induced and control rats were collected at
selected time points following treatment (Fig 1A). At Day 1, blood vessels and pancreatic ducts
within the exocrine tissue of diabetes-induced rats were grossly dilated as shown by H&E
staining (Fig 1B). This dilation was still somewhat visible at Day 4–7, although greatly reduced
at later time points (Day 11–14).
CD8+ cells and CD8+CD161+ cells infiltrate the pancreas during the pre-
insulitis period
Despite the high heterogeneity of human type 1 diabetes pancreas morphology, a consistent
finding is the identification of CD8 T cells as a major constituent when insulitis is present [12].
A further study from these same investigators revealed enhanced CD8 T cell infiltration within
the exocrine pancreas of type 1 diabetic individuals as well [10]. To determine whether the pan-
creata of diabetes-induced rats were also infiltrated by CD8 T cells, pancreas sections from dif-
ferent time points were stained with CD8 antibody. As expected, the majority of islets at Day
11–14, the insulitis stage, had abundant CD8+ cells, and no CD8+ cells were detected in the
islets prior to this stage (Fig 1C). In contrast, during the pre-insulitis period, starting at Day 1,
the pancreatic exocrine tissue of diabetes-induced rats had a dramatic increase in the number of
CD8+ cells compared to the control rats (Fig 1D). Because initially the CD8+ cells were not
near the islet areas, the islet (Fig 1C) and CD8+ cells (Fig 1D) are shown in separate views.
To further characterize and quantify the CD8+ cells that were infiltrating the pancreas, the
recovered cells isolated from the exocrine pancreas were stained for flow cytometric analysis.
Because CD8 is also expressed on NK cells in the rat [19], we included an antibody for CD161
(NK cell marker) as well as CD3 (T cell marker). Representative gating for CD3+CD8+CD161+
NKT cells and CD3-CD8+CD161high NK cells is shown in Fig 2A. Consistent with our immu-
nohistology data, many pancreas-infiltrating immune cells were indeed CD8+. At Day 1 post-
induction, compared to control rats the diabetes-induced rats showed a significant increase in
percentage of CD8+ T cells (Fig 2B) and NKT cells (Fig 2C). Interestingly, the percentage of
both CD8+ T cells and NKT cells returned to control levels by Day 7, but were again signifi-
cantly increased compared to control rats at Day 11 post-induction, coinciding with the start of
insulitis. The percentage of CD3-CD161high CD8+ NK cells in the exocrine pancreata of the dia-
betes-induced rats were significantly increased only at Day 1 and returned to control levels by
Day 4 (Fig 2D).
Apoptosis in whole pancreata of diabetes-induced rats occurs prior to its
detection in islets
We have previously shown that islets isolated from diabetes-induced rats undergo ER stress
and that the apoptosis marker, active (cleaved) caspase-3, is upregulated prior to insulitis [20].
Consistent with our previous report, active caspase-3 in isolated islets of diabetes-induced rats
was first observed at Day 7, with increased apoptosis observed at Days 11–14 when insulitis
was evident (Fig 3A and 3B). Here we extend that observation and additionally compare the
expression of active caspase-3 in protein lysates from whole pancreas of diabetes-induced rats.
Ultrasound imaging to predict type 1 diabetes risk
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Immunoblot analyses of pancreata from diabetes-induced rats showed significant evidence of
apoptosis as early as Day 1 post-induction (Fig 3C and 3D). Levels of active caspase-3 from the
pancreata of diabetes-induced rats continued to increase at later time points (Days 4 and 7) in
the pre-insulitic period, as well as during insulitis at Days 11–14 post-induction. As expected,
active caspase-3 was undetectable in isolated islets (Fig 3A) and whole pancreata (Fig 3B) of
control rats. These data suggest that the pancreatic exocrine tissues undergo apoptosis well
before the islets of the diabetes-induced rats.
Fig 1. Pancreas inflammation in diabetes-induced rats occurs prior to insulitis while islet morphology is normal. (A) Pancreas tissue was
collected from pIC+KRV treated and control rats at the time points indicated and processed for histology and immunostaining. (B) Representative
images of H&E stained pancreas sections from pIC+KRV treated and control rats. n = 6 rats/time point; scale bars, 100 um. Arrows indicate vessel/
duct dilation. Representative immunofluorescent images of islets (C) and exocrine tissue (D) from pancreas sections of pIC+KRV treated and
control rats; CD8 (red), insulin (green), DNA (blue). n = 4 rats/time point; scale bars, 50 um. Arrows indicate CD8+ cells.
https://doi.org/10.1371/journal.pone.0178641.g001
Ultrasound imaging to predict type 1 diabetes risk
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Ultrasound visualization of major blood vessels and the respective
organs they perfuse
Our H&E histology (Fig 1B) showed pronounced dilation of the blood vessels/ducts in the
pancreata of the diabetes-induced rats. To determine if ultrasound technology could provide a
useful means to visualize this pancreatic inflammation in a live animal, we first located the rel-
evant major blood vessels and the respective organs they supply/perfuse. Due to its size, the
abdominal aorta was the easiest vessel to visualize. As shown schematically in Fig 4A, the
splenic, renal, and continuing distally, the superior mesenteric arteries, were then identified.
Following the splenic and left renal arteries, the spleen and left kidney were located and used
as anatomical landmarks to locate the pancreas by 2D imaging (Fig 4B and 4C). The 3D imag-
ing (Fig 4D and 4E) was then mathematically rendered from the 2D imaging.
Fig 2. CD8+ cells infiltrate the pancreas at a very early time point after diabetes induction. Pancreas infiltrating immune cells were
analyzed at the indicated times from control rats (red circles) and pIC+KRV treated rats (blue squares) by flow cytometry. (A) Representative
flow gating for pancreatic supernatant on Day 1. Single, live cells were gated based on expression of CD45; CD45+ cells were further gated
on CD3 expression. CD3+ cells were divided into CD4+ and CD8+ cells and expression of CD161 was further analyzed on CD3+CD8+ cells.
Additionally, CD45+ cells that were CD3-CD161high were further analyzed for expression of CD8. Shown are percentages of CD8+CD3
+ cells of the CD45+ population (B), CD3+CD8+CD161+ NKT cells (C), and CD3-CD161highCD8+ NK cells (D): n = 6, each dot represents
data from a single rat. Comparison is between control and pIC+KRV treated rats at each time point; *p<0.05, **p<0.01 and ***p<0.001.
https://doi.org/10.1371/journal.pone.0178641.g002
Ultrasound imaging to predict type 1 diabetes risk
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Increased perfusion of pancreatic micro-vasculature in diabetes-induced
rats one day post-induction
To assess small blood vessel/capillary characteristics within different organs, a combination of
ultrasound and perfusion techniques was used. In this study, MicroMarker Contrast Imaging
Fig 3. Caspase 3 is activated much earlier in whole pancreas than islets in diabetes-induced rats.
Protein lysates from whole pancreata or isolated islets from pIC+KRV treated and control rats were collected at
the time points indicated. Representative Caspase 3 immunoblots of isolated pancreatic islets (A) and whole
pancreas (C) from pIC+KRV treated and control rats; actin was used as a loading control. Densitometric
analyses of the immunoblots from isolated pancreatic islets (B) and whole pancreata (D), normalized to actin.
n = 3, error bars show SE. ***p<0.001 for pIC+KRV treated versus control rats.
https://doi.org/10.1371/journal.pone.0178641.g003
Fig 4. Ultrasound imaging technology can identify various blood vessels and organs, including the pancreas. (A) Schematic drawing of
major blood vessels that were used as landmarks to locate the pancreas with ultrasound imaging technology. (B-D) Visualization by ultrasound
imaging technology of the pancreas, spleen and left kidney of a representative control rat using the splenic and left renal arteries as location
references. Representative image using 2D imaging mode (B-C) and using 3D imaging mode (D-E).
https://doi.org/10.1371/journal.pone.0178641.g004
Ultrasound imaging to predict type 1 diabetes risk
PLOS ONE | https://doi.org/10.1371/journal.pone.0178641 June 12, 2017 8 / 16
Mode combined with Non Linear Contrast Mode ultrasound technology were used to quantify
small vessels/capillaries of selected organs, particularly the pancreas. Rats from both diabetes-
induced and control groups were perfused with micro-bubbles by i.v. injection through the
tail vein. Representative ultrasound images for a diabetes-induced rat are shown prior to
micro-bubble injection (Fig 5A) and at peak of perfusion following injection (Fig 5B). The raw
perfusion data for pancreas and spleen from this same rat are shown in Fig 5C; such data are
linearized (as depicted in Fig 5D) to obtain the respective wash-in area, wash-in rate and peak
enhancement data. The wash-in rate reflects how quickly the micro-vasculature of the area of
interest takes to reach peak perfusion, whereas the wash-in area and peak enhancement indi-
cate the relative blood volume in the area of interest. Diabetes-induced rats monitored at Day
1 post-induction had significantly larger wash-in area, higher peak enhancement, and faster
wash-in rate than the control rats (Fig 5E). These analyses indicate that the micro-vasculature
in the pancreata of diabetes-induced rats was dramatically dilated very early following induc-
tion. However, this micro-vascular dilation in the diabetes-induced rats was only observed at
Day 1, not at Days 6 and 11 post-induction. Consistent with this, our H&E staining (Fig 1B)
also showed the greatest pancreatic blood vessel dilation at Day 1. A representative video
shows micro-bubble perfusion through the pancreas of a treated rat (S1 Fig).
Reduction in vessel resistance of the superior mesenteric artery of
diabetes-induced rats prior to and at onset of insulitis
Although micro-bubble perfusion allowed detection of micro-vasculature changes in the pan-
creata of diabetes-induced rats, the ideal use of ultrasound as a clinical diagnostic tool would
be totally non-invasive, with no injection at all. Ultrasound is a superior method to analyse
large blood vessels, therefore to determine whether this technology is able to detect measurable
phenotypic changes in large blood vessels prior to diabetes onset, we examined vessel resis-
tance of the superior mesenteric artery of diabetes-induced and control rats. The superior
mesenteric artery (SMA), which supplies oxygenated blood to the head and body of the pan-
creas and the intestine, was identified (Fig 6A). Using Pulsed Wave Doppler mode the peak
systolic and end diastolic velocities were measured (Fig 6B) and used to calculate the Resistivity
Index, which reflects the blood vessel resistance to blood flow. Using the same rats from the
perfusion study above, the Resistivity Index of the superior mesenteric artery in the diabetes-
induced rats was found to be significantly lower at Day 6 and Day 11 post-induction compared
to the control rats (Fig 6C), indicating that the superior mesenteric artery was inflamed during
this period. Importantly, because this decreased Resistivity Index occurs well prior to insulitis
(Day 6) and is sustained through the onset of insulitis (Day 11), this may reflect more persis-
tent vascular changes that impact the pancreas prior to autoimmunity and diabetes onset.
Discussion
This study demonstrates that the inducible BBDR rat model is an excellent model to study
type 1 diabetes because it recapitulates many pathological characteristics observed in human
specimens. While islet morphology appeared to be normal prior to autoimmunity in the diabe-
tes-induced rats, the exocrine pancreas underwent dramatic changes at a very early stage of
disease initiation. These changes include dilation of blood vessels and ducts, and the infiltra-
tion of CD8+ cells, including NK and NKT cells. Enhanced CD8 T cell infiltration has been
reported within the exocrine pancreas of cadaveric type 1 diabetic pancreas specimens [10];
and, in 3 of 6 type 1 diabetic organ donors, the pancreas tissue showed evidence of Coxsackie
B4 enterovirus and islet infiltration that was mediated mainly by NK cells [21]. Our study
shows increased CD8+ cells within the exocrine pancreas of the diabetes-induced rats well
Ultrasound imaging to predict type 1 diabetes risk
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Fig 5. Perfusion of pancreatic micro-vasculature is highly elevated at the earliest stage following diabetes induction. MicroMarker
Contrast Imaging Mode combined with Non Linear Contrast were used to generate the ultrasound images shown. Representative ultrasound
images from a treated rat are shown (A) prior to micro-bubble injection and (B) at peak of perfusion following injection. (C) Raw perfusion data
for the pancreas (green) and spleen (yellow) of the same rat. (D) Schematic diagram of linearized perfusion data indicating wash-in rate, wash-in
area, and peak enhancement. (E) Measured wash-in area, wash-in rate, and peak enhancement of pIC+KRV treated and control rats at
selected time points; Day 1 (red), Day 6 (blue) and Day 11 (purple) post-induction and age-matched control rats (green). n = 3, error bars
represent SE; *p<0.05 and ***p<0.001 for Day 1 pIC+KRV treated rats versus all other groups.
https://doi.org/10.1371/journal.pone.0178641.g005
Ultrasound imaging to predict type 1 diabetes risk
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prior to insulitis, suggesting a role for pancreatic inflammation in autoimmune diabetes initia-
tion and progression. In a previous study, we reported that islets undergo cell death via ER
stress prior to insulitis, here we show that exocrine pancreas cell death occurred even before
islet cell death was detected [20]. Ultrasound imaging showed that exocrine pancreas micro-
vasculature was significantly dilated shortly after diabetes induction, and large blood vessel
inflammation occurred several days later and was maintained through insulitis. Together,
these data demonstrate significant pancreas and blood vessel changes in the diabetes-induced
rat prior to autoimmunity—that can be visualized longitudinally by ultrasound imaging tech-
nology in living animals.
In a study with the NOD (non-obese diabetes) mouse, MRI imaging with magneto-fluores-
cent nanoparticles was used to visualize microvascular leakage, an indicator of inflammation
at the stage of autoimmunity [22]. Visualization of pancreas inflammation using MRI imaging
has recently been attempted in humans using the magnetic nanoparticle ferumoxytol [23].
These investigators found an increase in whole pancreas nanoparticle accumulation, which
reflects uptake by macrophages in the inflamed pancreas of recent-onset type 1 diabetic pa-
tients. However, ferumoxytol is not approved for patients under 18 years of age, and type 1 dia-
betes is typically diagnosed in young children. We chose to use ultrasound imaging technology,
Fig 6. Vessel resistance in the superior mesenteric artery is significantly reduced at later stages following diabetes induction.
Ultrasound imaging was first used to locate the superior mesenteric artery (SMA) and Pulsed Wave Doppler mode was then used to measure
its peak systolic and end diastolic velocity. (A) Representative ultrasound image showing the location of the SMA, aorta, and kidney. (B)
Representative ultrasound image using Pulsed Wave Doppler mode to measure peak systolic and end diastolic velocity of the SMA for
calculation of the Resistivity Index. The lower green and yellow lines show vital signs for heart rate and breathing cycle, respectively, from a
control rat. (C) The calculated Resistivity Index of the SMA of pIC+KRV treated and control rats at the times indicated. n = 3, error bars show
SE; *p<0.05 for Day 6 and Day 11 pIC+KRV treated rats versus Day 1 pIC+KRV treated rats and age-matched control rats.
https://doi.org/10.1371/journal.pone.0178641.g006
Ultrasound imaging to predict type 1 diabetes risk
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as it might be a more clinically favorable imaging tool to use with children, and is more cost effi-
cient and convenient than MRI imaging. The micro-bubble we used consisted of a lipid shell
with air inside that burst in a few minutes and left no trace afterwards. Currently, this micro-
bubble technique is available in clinics in Europe, and is allowed for some clinical applications
in the United States. This technique may enable investigation of pre-diabetic stages early in the
course of the disease, thus allowing time for potential therapeutic intervention at even earlier
stages before disease onset.
Indeed, we show here that ultrasound imaging technology was able to visualize pancreatic
micro-vasculature inflammation in the diabetes-induced rats one day following pIC+KRV
treatment. In support of this, we previously found that pro-inflammatory IL-1β levels in sera
of diabetes-induced rats were significantly increased at the same time point [24]. In humans,
multiple pro-inflammatory cytokines, including IL-1β, were significantly higher in children
positive for islet autoantibodies [25]. The involvement of the innate immune response and IL-
1 regulated genes was also supported by a functional genomics study of human sera [26]. Fur-
thermore, gene expression and genetic association studies support a link between the innate
immune response and susceptibility to human type 1 diabetes [27]. Consistent with this, C4d,
a marker of complement activation, was also increased in the pancreata of type 1 diabetic
donors, and was localized to the endothelium and extracellular matrix surrounding pancreatic
blood vessels and ductal structures, as well as the endothelium of pancreatic capillaries [28].
Taken together these studies indicate the presence of pancreatic inflammation during type 1
diabetes.
Besides dilation of micro-vasculature, the inflammatory process can also involve increasing
blood flow and vascular permeability. In diabetes-induced rats, large blood vessels (superior
mesenteric artery in our study) also had lower resistance prior to insulitis, which shows that
blood vessel dilation indicative of inflammation also occurred in larger blood vessels. It is
important to note that dilation of large vessels supplying the pancreas of diabetes-induced rats
was first detectable by ultrasound at a later time point (Day 6), after the acute micro-vascula-
ture dilation observed at Day 1 had subsided, but still prior to the onset of insulitis. Indeed,
Pulsed Wave Doppler mode ultrasound imaging continued to show statistically significant
dilation of the superior mesenteric artery that supplies the pancreas through the onset of insu-
litis (Day 11), indicating that these inflammatory changes may be sustained, rather than merely
a transient response. If so, ultrasound technology may prove useful in the clinic for longitudi-
nal studies to distinguish individuals undergoing a transient inflammatory viral infection that
resolves without leading to induction of autoimmunity, from those in the early stages of dis-
ease development whose pancreas inflammation would persist. In support of this, evidence of
ongoing pancreatic inflammation has been reported in autoantibody-positive non-diabetic
donors as well as known diabetic donors [14].
Based on the data reported here, we hypothesize that type 1 diabetes development in some
genetically-susceptible individuals may start with an environmental perturbation, such as a
viral infection, and this perturbation may induce inflammation both systemically and in multi-
ple organs, including the pancreas. We speculate that pancreas inflammation, in proximity to
islet β-cells, may have direct pathological effects on islet health, such as ER stress, and progress
to some initial β-cell death as we have previously observed [20]. In turn, the signals released
from these stressed and dying β-cells, in conjunction with an unresolved innate immune
response, may reach a critical ‘threshold’ for autoimmune activation in those individuals
genetically at-risk, and lead to insulitis and a further substantial autoimmune-mediated
destruction of β-cells. In this scenario, the individual’s innate [24] immune response to the
virus may be more important in the initial β-cell destruction than a direct role for the virus
itself.
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In support of this, in our previous studies, we compared the serum levels of inflammatory
proteins in rats treated with pIC+KRV or pIC+H1 virus [24, 29]. Although H1 and KRV are
both parvoviruses with 98% sequence identity, pIC+H1 treatment does not induce diabetes
[30]. Briefly, on day 1, both pIC+KRV and pIC+H1 treated rats had a ~15-fold increase in
serum haptoglobin, an acute phase protein. Although haptoglobin levels in pIC+H1 treated
group subsequently declined, the levels in pIC+KRV treated rats remained elevated through
day 7. The inflammatory cytokines, IL-1β and IL-6, were increased in rats treated with pIC
+KRV, but levels in pIC+H1 treated rats were not significantly different from those of PBS
treated controls. Also, serum levels of IL-12 in rats with pIC+KRV treatment were elevated
and remained elevated at later time points, whereas pIC+H1 treatments failed to induce IL-12
at any time point. Furthermore, pancreas histology of pIC+H1 treated rats did not show the
typical dilation of blood vessels and ducts, and CD8 staining was similar to the PBS treated
control group. In summary, the data suggested that pIC+KRV treated rats had greater innate
immune activation, and this activation persisted for a longer period than in the pIC+H1
treated group.
Indeed, the role of innate immunity in the development of type 1 diabetes is supported by
genetic and functional studies in both animal models and humans [25–27, 31–36]. Impor-
tantly, increased innate immune activity has been reported in genetically at-risk children even
prior to detection of serum autoantibodies [37, 38]. In view of this, we envision that the most
effective use of ultrasound to identify at-risk children at the very earliest stages of disease devel-
opment would involve assessment of pancreas inflammation when these children present with
a fever, such as may occur with a presumed viral infection. These at-risk children would be
monitored by ultrasound again a few weeks after the fever has resolved to identify persistent
pancreas inflammation. If pancreatic inflammation continues, these children could be more
closely examined for other indicators of impending type 1 diabetes, such as the presence of
serum autoantibodies. Ideally, this would also be an appropriate time to begin preventative
treatments, when they become available.
Conclusions
In conclusion, ultrasound is an excellent non-invasive tool to visualize changes in blood vessel
and blood flow that are characteristic of an inflammatory response. Our data show that sus-
tained pancreas inflammation prior to disease onset can be detected by ultrasound in our dia-
betes-induced rats. For research purposes, the ability to longitudinally monitor pancreas
changes in animal models of type 1 diabetes is critical to interrogating the pancreas’ role
throughout disease progression, as well as to identify potential treatments that facilitate pan-
creas health. In combination with perfusion techniques, ultrasound also allows assessment of
small blood vessels/capillaries in the pancreas during type 1 diabetes pathogenesis. Currently,
this contrast ultrasound technique (e.g., with micro-bubble injection) is available in clinics in
Europe, and is cleared by the Food and Drug Administration for some clinical applications in
the U.S. Importantly, due to its established use as a safe and effective clinical diagnostic tool,
ultrasound technology could be explored as one methodology to aid in the early prediction of
type 1 diabetes in the at-risk population, and to assess early treatment strategies that may be
developed to prevent type 1 diabetes.
Supporting information
S1 Fig. Representative video showing microbubble perfusion through the pancreas of a
diabetes-induced rat. MicroMarker Contrast Imaging Mode combined with Non Linear Con-
trast mode were used to generate the ultrasound images shown. Video shows a time lapse of
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426 seconds following microbubble injection.
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